Not all cells used to manufacture biologic medicine are created equal, and plant cell biologics like Lemna may be the most efficient option the industry hasn't scaled yet.
Most biologic medicine is made inside living animal cells, and the cost of making it safe for humans gets passed directly to patients. Plant cell manufacturing could change that.
Hi, I'm Susan. Biotech founder, former pharmaceutical manufacturing executive, and breast cancer survivor. I spent 30 years inside this industry, and I'm proud of that work. It has saved millions of lives, including mine. But when you know what you know, you can't stay quiet.
@PhRMA And what sorts of tools will arise (or are arising already) to screen, produce, choose, test and regulate that # of choices? Innovation creating more innovation….
It’s important that you understand what happened last night.
Last night, Stephen Colbert interviewed Democratic Texas Senate candidate James Talarico, a candidate who, by all accounts, is on track in the polls to flip Texas blue.
In response, Trump’s FCC reportedly threatened CBS if the interview aired.
CBS caved and pulled the segment, citing “financial reasons.”
In modern American history, no president has been more hostile to free speech than Donald Trump.
But censorship always backfires.
Here’s the full segment Trump didn’t want you to see.
This is troubling for multiple reasons, but a big one is companies won’t invest in R&D and clinical trials if they don’t think they can get a fair regulatory review—which is at the end of a long and extremely expensive process.